by Truveta staff | Jul 30, 2024 | Data
By the time most women with ovarian cancer are diagnosed, 70-80% are already at an advanced stage of the disease. Despite declining mortality rates over the past decade, the 5-year survival rate for patients with ovarian cancer remains less than 30%. Sometimes...
by Truveta staff | May 30, 2024 | Technology
This post is the first of six deep dives I plan to do into the significant technology challenges we have solved at Truveta using the power of AI to enable healthcare research using real-world data. Today I would like to talk about our approach to answering: How to...
by Truveta staff | May 20, 2024 | Data
You probably know someone who will be diagnosed with prostate cancer in their lifetime. 1 in 8 men will develop prostate cancer, with a higher risk in Black and African American men and an overall increased risk after the age of 65. While most cases are not fatal,...
by Truveta staff | May 13, 2024 | Research
Recently, researchers presented new insights from a continued analysis of the REAL-PE study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. To address a lack of sufficient clinical guidance on how to best treat pulmonary embolism...
by Truveta staff | Apr 18, 2024 | Data
In 2019, the US government unveiled the ambitious Ending the HIV Epidemic (EHE) plan, aiming to slash new HIV infections by 90% by 2030. Thanks to advances in antiretroviral therapy (ART), proven models of prevention, and data access, new HIV infections declined 12%...
